Market Newsdesk

MONETT, Mo., Aug. 10, 2021 /PRNewswire/ — Jack Henry & Associates, Inc.^® (NASDAQ:JKHY) is a leading provider of technology solutions and payment processing services primarily for the financial services industry. Its Symitar^® division today announced that TruStone Financial Credit Union is leveraging its open technologies to maintain a personal touch with members throughout its merger and beyond.

Previously operating as TruStone Financial Credit Union and Firefly Credit Union, the credit union merger integration was completed in March. The credit union uses Symitar’s core as well as the Banno Digital Platform™, inclusive of payments and other complementary features. Leveraging Jack Henry’s technology was a critical component in the transition. TruStone serves on Banno’s Customer Advisory Board and participates in pilot and beta testing.

Dale Turner, president and CEO of TruStone, said, “It’s clear that Jack Henry considers feedback and strategic direction when innovating on behalf of their clients, which was an influencing factor for our decision to partner withthem throughout the merger and into the future of our credit union. This merger was a huge milestone in the history of our credit union and we needed a partner who can support the needs of our business as well as our members with modern technology. We are confident in working witha partner who is proven to listen, value our business, and constantly innovate on our behalf.”

Firefly was previously on a competitor’s core before the merger, but the newly merged credit union decided to continue its relationship with Jack Henry because of the immediate efficiency gains and established infrastructure. TruStone was also already leveraging the Banno Digital Platform; now that the merger is complete over 100,000 members benefit from this digital experience. Not only will members enjoy better feature functionality such as live, secure human chats and faster speeds, including the app-launch-to-transaction view of 1-2 seconds, as well as human-centered digital banking experiences, but will have direct and open access to popular third-party applications.

Turner added, “We’ve learned many lessons during Covid-19 about rapid adoption and use of digital services. Dynamic systems are table stakes – we need to be quick and responsive to a rapidly evolving digital landscape.”

Shanon McLachlan, vice president of Jack Henry & Associates and president of Symitar, said, “Mergers can be challenging regardless of the circumstance, and this merger was the largest of its kind in credit union history. We’re honored that TruStone and Firefly trusted our decades  of experience  to make the transition as seamless as possible. This time is often when partnerships are re-evaluated, but for us, it’s a true testament to the strength of our relationships and the value our technology brings to both the institution and its members. We look forward to growing our relationship with TruStone and continuing to support their journey.”

About Symitar 
Symitar, a division of Jack Henry & Associates, Inc.^®, is the leading provider of integrated computer systems for credit unions of all sizes. Symitar has been selected as the primary technology partner by more than 700 credit unions, serving as a single source for integrated, enterprise-wide automation and as a single point of contact and support. Additional information is available at www.symitar.com. 

About Jack Henry & Associates, Inc.

Jack Henry (NASDAQ: JKHY) is a leading provider of technology solutions primarily for the financial services industry. We are an S&P 500 company that serves approximately 8,500 clients nationwide through three divisions: Jack Henry Banking^® supports banks ranging from community banks to multi-billion-dollar institutions; Symitar^® provides industry-leading solutions to credit unions of all sizes; and ProfitStars^® offers highly specialized solutions to financial institutions of every asset size, as well as diverse corporate entities outside of the financial services industry. With a heritage that has been dedicated to openness, partnership, and user centricity for more than 40 years, we are well-positioned as a driving market force in future-ready digital solutions and payment processing services. We empower our clients and consumers with the human-centered, tech-forward, and insights-driven solutions that will get them where they want to go. Are you future ready? Additional information is available at www.jackhenry.com.

Statements made in this news release that are not historical facts are forward-looking information.  Actual results may differ materially from those projected in any forward-looking information.  Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated by any forward-looking information.  Additional information on these and other factors, which could affect the Company’s financial results, are included in its Securities and Exchange Commission (SEC) filings on Form 10-K, and potential investors should review these statements.  Finally, there may be other factors not mentioned above or included in the Company’s SEC filings that may cause actual results to differ materially from any forward-looking information.  

JKHY-SY  

 

View original content:https://www.prnewswire.com/news-releases/jack-henry-supports-trustone-financial-credit-union-through-merger-of-scale-301351843.html

SOURCE Jack Henry & Associates, Inc.

DALLAS, Aug. 10, 2021 /PRNewswire/ — Ashford Inc. (NYSE American: AINC) (“Ashford” or the “Company”) today announced that on August 9, 2021, the Company received written notice from the NYSE American LLC (the “Exchange”) stating that the Company has regained compliance with all of the continued listing standards set forth in Part 10, Section 1003 of the NYSE American Company Guide (the “Company Guide”).

By meeting the continued listing requirements, Ashford has resolved its continued listing deficiency and, effective at the start of trading on August 10, 2021, the “.BC” designation, signifying noncompliance with the Exchange’s listing standards, will be removed from the “AINC” trading symbol.

“We are pleased to have regained compliance with the NYSE American’s continued listing standards, and remain focused on the execution of our strategic plan,” commented Jeremy J. Welter, Ashford’s President and Chief Operating Officer. “Ashford has an unwavering commitment to maximize value for our shareholders and we remain focused on our unique investment strategy to strategically invest in operating companies that service the hospitality industry and act as an accelerator to grow these companies.  The Ashford group of companies are well-positioned to capitalize on the continuing recovery in the hospitality industry and I am excited about the future prospects for our Company.”

As previously announced, on August 26, 2020 the Company received a notification letter (the “Letter”) from the Exchange, which indicated that the Company was not in compliance with the continued listing standards of Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide. Pursuant to these Sections, the Exchange will normally consider suspending dealings in, or removing from the list, securities of a listed company whose stockholders’ equity is less than (i) $2.0 million if it has reported losses from continuing operations or net losses in two of its three most recent fiscal years and (ii) $4.0 million if it has reported losses from continuing operations or net losses in three of its four most recent fiscal years (together, the “Stockholders’ Equity Standards”).   However, Section 1003(a) of the Company Guide also states that the Exchange will not normally consider suspending dealings in, or removing from the list, the securities of a listed company that falls below the Stockholders’ Equity Standards if the listed company is in compliance with the following two standards: (1) total value of market capitalization of at least $50 million or total assets and revenue of $50 million each in its last fiscal year, or in two of its last three fiscal years (the “First Standard”), and (2) the listed company has at least 1.1 million shares publicly held, a market value of publicly held shares of at least $15.0 million and 400 round lot shareholders (the “Second Standard”).

When the Company received the Letter, it was not in compliance with the Stockholders’ Equity Standards, but it was in compliance with the First Standard because it had total assets and total revenue of at least $50 million in its last fiscal year and was in compliance with the Second Standard, except that the current market value of publicly held shares was below $15.0 million. 

On September 24, 2020, the Company submitted to the Exchange a compliance plan which detailed how it intended to regain compliance with Section 1003(a) by increasing the current market value of the publicly held shares above $15.0 million while maintaining compliance with all other requirements of the First and Second Standards.

As of June 30, 2021, the Company did not meet the requisite Stockholders’ Equity Standards. However, as a result of management’s efforts, the Company has come into compliance with the First and Second Standards, and the Exchange has informed the Company that it has cured the previously cited deficiencies and is in full compliance with the continued listing standards set forth in Part 10, Section 1003 of the Company Guide.

Ashford provides global asset management, investment management and related services to the real estate and hospitality sectors.

Certain statements and assumptions in this press release contain or are based upon “forward-looking” information and are being made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, among others, statements about the Company’s strategy and future plans. These forward-looking statements are subject to risks and uncertainties. When we use the words “will likely result,” “may,” “anticipate,” “estimate,” “should,” “expect,” “believe,” “intend,” or similar expressions, we intend to identify forward-looking statements. Such statements are subject to numerous assumptions and uncertainties, many of which are outside Ashford Inc.’s control.

These forward-looking statements are subject to known and unknown risks and uncertainties, which could cause actual results to differ materially from those anticipated, including, without limitation: the impact of COVID-19, including one or more possible recurrences of COVID-19 case surges that would cause state and local governments to reinstate travel restrictions and the rate of adoption and efficacy of vaccines to prevent COVID-19, on our business and investment strategy; our ability to continue as a going concern; the timing and outcome of the Securities and Exchange Commission’s investigation; our ability to maintain compliance with NYSE American LLC continued listing standards; our ability to regain Form S-3 eligibility; our ability to repay, refinance or restructure our debt and the debt of certain of our subsidiaries; anticipated or expected purchases or sales of assets; our projected operating results; completion of any pending transactions; our understanding of our competition; market trends; projected capital expenditures; the impact of technology on our operations and business; general volatility of the capital markets and the market price of our common stock and preferred stock; availability, terms and deployment of capital; availability of qualified personnel; changes in our industry and the markets in which we operate, interest rates or the general economy; and the degree and nature of our competition. These and other risk factors are more fully discussed in the Company’s filings with the Securities and Exchange Commission.

The forward-looking statements included in this press release are only made as of the date of this press release. Such forward-looking statements are based on our beliefs, assumptions, and expectations of our future performance taking into account all information currently known to us. These beliefs, assumptions, and expectations can change as a result of many potential events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity, results of operations, plans, and other objectives may vary materially from those expressed in our forward-looking statements. You should carefully consider this risk when you make an investment decision concerning our securities. Investors should not place undue reliance on these forward-looking statements. The Company can give no assurance that these forward-looking statements will be attained or that any deviation will not occur. We are not obligated to publicly update or revise any forward-looking statements, whether as a result of new information, future events or circumstances, changes in expectations, or otherwise, except to the extent required by law.

View original content:https://www.prnewswire.com/news-releases/ashford-regains-compliance-with-nyse-american-continued-listing-standards-301351737.html

SOURCE Ashford Inc.

LAS VEGAS, Aug. 10, 2021 /PRNewswire/ — Allegiant (NASDAQ: ALGT) today announces 22 new nonstop routes, expanding service in 25 cities across the United States. To celebrate, Allegiant is offering one-way fares on the new routes as low as $39.*

“A hallmark of Allegiant’s service is to connect travelers to warmer destinations where they can enjoy a variety of outdoor leisure activities,” said Drew Wells, Allegiant’s senior vice president of revenue and network planning. “And we’ve continued that tradition with this expansion by giving customers more affordable, nonstop options to visit Florida, Arizona and California during the fall and winter seasons.”

More than ever, travelers appreciate the convenience Allegiant provides by offering nonstop flights that get them from point-to-point, without the hassle of layovers or connections, Wells said. They also like the convenient access through the smaller airports Allegiant serves in communities that have traditionally lacked commercial air service.

The new routes to Destin-Fort Walton Beach Airport (VPS) in Floridainclude:

1. 
   Minneapolis, Minnesota via Minneapolis-Saint Paul International Airport (MSP) – beginning Oct. 1, 2021 with one-way fares as low as $49.*
2. 
   Las Vegas, Nevada via McCarran International Airport (LAS) – beginning Oct. 7, 2021 with one-way fares as low as $39.*

The new routes to Phoenix-Mesa Gateway Airport (AZA) in Arizonainclude:

1. 
   Amarillo, Texas via Rick Husband Amarillo International Airport (AMA) – beginning Nov. 18, 2021 with one-way fares as low as $39.*
2. 
   Flint, Michigan via Flint Bishop International Airport (FNT) – beginning Nov. 18, 2021 with one-way fares as low as $59.*
3. 
   Springfield, Illinois via Abraham Lincoln Capital Airport (SPI) – beginning Nov. 18, 2021 with one-way fares as low as $59.*
4. 
   Tulsa, Oklahoma via Tulsa International Airport (TUL) – beginning Nov. 18, 2021 with one-way fares as low as $49.*
5. 
   Orange County, California via John Wayne Airport (SNA) – beginning Nov. 19, 2021 with one-way fares as low as $39.*
6. 
   Spokane, Washington via Spokane International Airport (GEG) – beginning Nov. 22, 2021 with one-way fares as low as $39.*
7. 
   Minneapolis, Minneapolis via Minneapolis-Saint Paul International Airport (MSP) – beginning Nov. 24, 2021 with one-way fares as low as $49.*

The new routes toPalm Springs International Airport (PSP) in Californiainclude:

1. 
   Des Moines, Iowa via Des Moines International Airport (DSM) – beginning Nov. 18, 2021 with fares as low as $59.*
2. 
   Indianapolis, Indiana via Indianapolis International Airport (IND) – beginning Nov. 18, 2021 with fares as low as $59.*
3. 
   Provo, Utah via Provo Airport (PVU) – beginning Nov. 19, 2021 with fares as low as $39.*

The new routes to Austin-Bergstrom International Airport (AUS)in Texas include:

1. 
   Punta Gorda, Florida via Punta Gorda Airport (PGD) – beginning Nov. 18, 2021 with one-way fares as low as $49.*
2. 
   Palm Beach, Florida via Palm Beach International Airport (PBI) – beginning Nov. 19, 2021 with fares as low as $49.*

The new routes to Minneapolis-Saint Paul International Airport (MSP) in Minnesotainclude:

1. 
   Destin, Florida via Destin-Fort Walton Beach Airport (VPS) – beginning Oct. 1, 2021 with one-way fares as low as $49.*
2. 
   Mesa, Arizona via Phoenix-Mesa Gateway Airport (AZA) – beginning Nov. 24, 2021 with one-way fares as low as $49.*

The new routes to Punta Gorda Airport (PGD)in Florida include:

1. 
   Bentonville, Arkansas via Northwest Arkansas National Airport (XNA) – beginning Nov. 17, 2021 with one-way fares as low as $49.*
2. 
   Austin, Texas via Austin-Bergstrom International Airport (AUS) – beginning Nov. 18, 2021 with fares as low as $49.*

The new routes to Provo Airport (PVU) in Utahinclude:

1. 
   Houston, Texas via William P. Hobby Airport (HOU) – beginning Nov. 18, 2021 with one-way fares as low as $39.*
2. 
   Palm Springs, California via Palm Springs International Airport (PSP) – beginning Nov. 19, 2021 with fares as low as $39.*

The new routes to John Wayne Airport (SNA) in California include:

1. 
   Mesa, Arizona via Phoenix-Mesa Gateway Airport (AZA) – beginning Nov. 19, 2021 with fares as low as $39.*
2. 
   Sioux Falls, South Dakota via Sioux Falls Regional Airport (FSD) – beginning Nov. 19, 2021 with one-way fares as low as $49.*

The new routes to Sioux Falls Regional Airport (FSD) in South Dakotainclude:

1. 
   Orange County, California via John Wayne Airport (SNA) – beginning Nov. 19, 2021 with one-way fares as low as $49.*
2. 
   Fort Lauderdale, Florida via Fort Lauderdale-Hollywood International Airport (FLL) – beginning Dec. 15, 2021 with one-way fares as low as $59.*

The new routes to Sarasota Bradenton International Airport (SRQ) in Floridainclude:

1. 
   Cedar Rapids, Iowa via The Eastern Iowa Airport (CID) – beginning Nov. 19, 2021 with one-way fares as low as $49.*
2. 
   Tulsa, Oklahoma via Tulsa International Airport (TUL) – beginning Dec. 15, 2021 with one-way fares as low as $49.*

The new routes to Fort Lauderdale-Hollywood International Airport (FLL) in Floridainclude:

1. 
   Sioux Falls, South Dakota via Sioux Falls Regional Airport (FSD) – beginning Dec. 15, 2021 with fares as low as $59.*
2. 
   Harrisburg, Pennsylvania via Harrisburg International Airport (MDT) – beginning Dec. 15, 2021 with fares as low as $59.*
3. 
   Peoria, Illinois via Peoria International Airport (PIA) – beginning Dec. 15, 2021 with fares as low as $59.*

Flight days, times and the lowest fares can be found only at Allegiant.com.

*About the introductory one-way fares:

Seats and dates are limited and fares are not available on all flights. Flights for LAS – VPS must be purchased by Aug. 11, 2021 for travel by Nov. 14, 2021. All other flights must be purchased by Aug. 11, 2021 for travel by May 17, 2022. Price displayed includes taxes, carrier charges & government fees. Fare rules, routes and schedules are subject to change without notice. Optional baggage charges and additional restrictions may apply. For more details, optional services and baggage fees, please visit Allegiant.com.

Allegiant – Together We Fly^TM

Las Vegas-based Allegiant (NASDAQ: ALGT) is an integrated travel company with an airline at its heart, focused on connecting customers with the people, places and experiences that matter most. Since 1999, Allegiant Air has linked travelers in small-to-medium cities to world-class vacation destinations with all-nonstop flights and industry-low average fares. Today, Allegiant’s all-Airbus fleet serves communities across the nation, with base airfares less than half the cost of the average domestic roundtrip ticket. For more information, visit us at Allegiant.com. Media information, including photos, is available at http://gofly.us/iiFa303wrtF

Media Contact

Phone: 702-800-2020
Email: [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/allegiant-announces-major-service-expansion-with-22-new-nonstop-routes-301351508.html

SOURCE Allegiant Travel Company

OMAHA, Neb., Aug. 10, 2021 /PRNewswire/ — Jennifer Hamann, executive vice president and chief financial officer, and Eric Gehringer, executive vice president operations, of Union Pacific Corporation (NYSE: UNP), will address the Deutsche Bank 2021 Transportation Conference on Tuesday, August 17, 2021, at 9:00 a.m. ET.

A live webcast of the presentation will be available in the investor relations section of Union Pacific’s website at www.up.com/investor. A replay of the audio webcast will be available shortly thereafter.

ABOUT UNION PACIFIC

Union Pacific (NYSE: UNP) delivers the goods families and businesses use every day with safe, reliable and efficient service. Operating in 23 western states, the company connects its customers and communities to the global economy. Trains are the most environmentally responsible way to move freight, helping Union Pacific protect future generations. More information about Union Pacific is available at www.up.com.

www.up.com

www.facebook.com/unionpacific

www.twitter.com/unionpacific

View original content to download multimedia:https://www.prnewswire.com/news-releases/union-pacific-corporation-executives-to-address-the-deutsche-bank-2021-transportation-conference-301351550.html

SOURCE Union Pacific Corporation

LOS ANGELES, Aug. 10, 2021 /PRNewswire/ — Stand Up To Cancer® (SU2C) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announce a three-year, $4 million research collaboration to explore new opportunities, including lurbinectedin in pediatric solid tumors and pan-RAF molecules in RAF- and RAS-mutated solid cancers. The collaboration also includes digital ethnography research to identify barriers to treatment and to gain insights and perspectives about small cell lung cancer (SCLC) from patients and caregivers in underserved communities.

The collaboration supports Stand Up To Cancer’s efforts to accelerate the development of new treatments, and where appropriate, combination therapies for cancer patients through the Stand Up To Cancer Catalyst® program, which brings together industry and academic scientists in the cancer community. With an estimated 1.9 million new cancer cases diagnosed in the U.S. in 2021, innovative approaches that deliver new treatments to patients faster remain a key component of SU2C’s mission. The SU2C Catalyst program was created specifically to encourage innovative and collaborative clinical translational research between academics and companies with an emphasis on speed and collaboration.

The collaboration between SU2C and Jazz will provide SU2C-funded researchers access to two Jazz molecules as well as funds to support one or more research projects over a three-year period. One of the potential projects would help SU2C scientists explore for the first time the possible clinical use of lurbinectedin in rare and hard to treat pediatric solid tumors. Lurbinectedin, commercialized by Jazz in the U.S. as Zepzelca®, received accelerated approval by the U.S. Food and Drug Administration in June 2020 for the treatment of adult patients with metastatic SCLC with disease progression on or after platinum-based chemotherapy. Early studies have demonstrated that the therapy, which works by inhibiting tumor growth and promoting eventual tumor cell death, may be useful in treating several advanced adult and pediatric cancers.

“While incredible progress has been made in advancing pediatric cancer research, critical unmet needs still exist; we cannot make children wait for treatments to be tested in adults first,” said Sung Poblete, PhD, RN, CEO of Stand Up To Cancer. “SU2C started its Catalyst program to speed research of clinical compounds in both adults and children so that we can bring better treatments to patients quickly and save lives. Through this program, the Jazz-funded research offers exciting possibilities for childhood tumors as well as adult solid cancers that desperately need new treatment options.”

The collaboration may also support non-clinical studies of an investigational pan-RAF inhibitor compound called JZP815 in RAF- and RAS-mutated solid cancers, which make up about one-third of all cancers. Pan-RAF inhibitors work by inhibiting a common pathway for many cancers; the Jazz Pharmaceuticals research could enable studies of the compound in cancers where other drugs, called B-RAF inhibitors, have become ineffective.

“Our company’s purpose is to innovate to transform the lives of patients and their families, and we are committed to advancing our pipeline of innovative oncology therapies, including lurbinectedin and early-stage molecules, to identify new options for patients,” said Robert Iannone, MD, MSCE, executive vice president, research and development and chief medical officer of Jazz Pharmaceuticals. “As part of this commitment, Jazz is proud to collaborate with Stand Up To Cancer and support the SU2C Catalyst program, whose goal is to expedite the development of novel treatments for patients diagnosed with difficult-to-treat cancers. Our collaboration with Stand Up To Cancer will support, among other projects, a digital ethnography study in small cell lung cancer that we believe will generate insights into better care and health outcomes for diverse patient populations.”

The digital ethnography study will focus on better understanding the attitudes and perspectives of healthcare providers, patients and their families, in particular in underserved communities, on their experiences participating in and understanding sources of information on SCLC clinical trials.

“The SU2C Catalyst model brings the best and brightest minds to the table to find novel uses for drugs or drug compounds, so we have more opportunities to find new and innovative treatments for cancers that are particularly difficult to treat,” said Nobel laureate Phillip A. Sharp, PhD, chair of Stand Up To Cancer’s Scientific Advisory Committee and an institute professor at the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology. “With their growing solid tumor research and development pipeline, Jazz Pharmaceuticals will be an ideal collaborator in the program.”

SU2C’s Catalyst program began in 2016, with contributions from other leading industry supporters. Through the program, companies provide funds for collaborative research studies, in which use of the companies’ products and materials is strongly encouraged. Those materials might include new pharmaceutical compounds that companies are developing or approved agents that can be investigated for other uses. Two primary goals of SU2C Catalyst is to encourage collaborative research between academics and companies and shorten the time it takes to get new treatments to patients. 

About Stand Up To Cancer
Stand Up To Cancer® (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Industry Foundation, a 501(c)(3) charitable organization, was established in 2008 by media and entertainment leaders who utilize these communities’ resources to engage the public in supporting a new, collaborative model of cancer research, to increase awareness about cancer prevention, and to highlight progress being made in the fight against the disease. As of January 2021, more than 1,950 scientists representing more than 210 institutions are involved in SU2C-funded research projects.

Under the direction of our Scientific Advisory Committee, led by Nobel laureate Phillip A. Sharp, Ph.D., SU2C implements rigorous competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and ensure collaboration across research programs.

Current members of the SU2C Founders and Advisors Committee (FAC) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Sung Poblete, Ph.D., R.N., serves as SU2C’s CEO, and Russell Chew as SU2C’s President.

About Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.

View original content to download multimedia:https://www.prnewswire.com/news-releases/stand-up-to-cancer-and-jazz-pharmaceuticals-collaborate-to-fund-catalyst-research-on-hard-to-treat-cancers-301351643.html

SOURCE Stand Up To Cancer

DUBLIN, Ohio, Aug. 10, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) today announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19 tests through partnerships with Abbott and Quidel Corporation (“Quidel”).

Cardinal Health will leverage its expansive distribution network to support broad access to Quidel’s QuickVue® At-Home OTC COVID-19 Test and Abbott’s BinaxNOW™ COVID-19 Antigen Self-Test, which allow consumers to easily perform tests for the virus without a prescription. 

“Rapid over-the-counter tests will be pivotal in supporting the safe and sustained reopening of our country, especially as we see a rise in cases due to the Delta variant,” said Chris Kerski, senior vice president and general manager, Cardinal Health Laboratory Products. “Because we offer a full suite of solutions for COVID-19 testing, as well as vaccine transport and storage, Cardinal Health has been helping organizations and communities determine the best solutions for bringing their populations safely back out of the home since the pandemic began. We’re proud to say we now offer these over-the-counter products as part of our holistic laboratory products portfolio.”

With the addition of rapid at-home tests, Cardinal Health’s laboratory products portfolio can now support customized testing and surveillance programs for workplaces, the travel and hospitality industry, and schools with comprehensive solutions that include at-home tests, rapid on-site testing, PCR (molecular testing) and on-site or at-home specimen collection.

“Cardinal Health’s safe reopening offerings and broad channel presence will play a key role in widening access to testing,” said Douglas Bryant, president and chief executive officer, Quidel. “Quidel and Cardinal Health have collaborated closely since the start of the pandemic to serve the country with these COVID-19 testing solutions. On March 17, 2020, just days after the U.S. declared COVID-19 a national emergency, we received emergency use authorization of our high throughput PCR testing platform and, that very same day, announced that we partnered exclusively with Cardinal Health to distribute it rapidly and broadly. This was essential early-on in the global fight against the virus – and the work didn’t stop there.”

Bryant added, “Cardinal Health and Quidel continued working together on a massive distribution push to get our Sofia® SARS rapid antigen assay out to the largest health system in the U.S. – and this latest distribution partnership is another critical step forward in Quidel’s efforts to democratize access to our testing solutions, including our QuickVue® At-Home OTC COVID-19 antigen.”

COVID-19 OTC rapid tests allow employers, schools and individuals to easily implement screening and surveillance testing programs to identify both symptomatic and asymptomatic infections. While the effort to vaccinate more Americans continues, these programs will also remain a vital piece in mitigating the spread of COVID-19 as new variants like Delta emerge and with the potential for the virus to reemerge seasonally.

“As the most widely used and studied rapid COVID-19 antigen tests in the U.S., BinaxNOW has helped communities, schools, workplaces and families quickly identify infectious people and help stop the spread of the virus,” said Andrea Wainer, executive vice president, Rapid and Molecular Diagnostics, Abbott. “Partnering with Cardinal Health widens the distribution of our over-the-counter self-tests to more organizations around the country, providing people with answers quickly and in the comfort of their own homes.”

In addition to providing COVID-19 OTC rapid tests, Cardinal Health Laboratory Products provides consumables, including swabs and viral transport media, as well as customizable specimen collection kits to support the testing needs of laboratories and decentralized testing sites. It also provides a range of solutions for COVID-19 vaccine storage from the time it is manufactured until it’s administered. In addition, the company offers comprehensive testing solutions for respiratory viruses and other infectious diseases ranging from core lab molecular testing to rapid point-of-care platforms.

To read more about Cardinal Health Laboratory Products and its response to COVID-19, click here. For more information on Cardinal Health’s safe reopening offerings, click here.

About Cardinal Health

Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in more than 40 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Contacts

Media: Cari Wildasinn,
[email protected] and (614) 757-8287
Investors: Kevin Moran, [email protected] and (614) 757-7942

The BinaxNOW™ COVID-19 Antigen Self-Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. BinaxNOW COVID-19 Antigen Self-Test should be performed twice in 3 days, at least 36 hours apart.

The QuickVue^® At-Home OTC COVID-19 Test is only for use under the Food and Drug Administration’s Emergency Use Authorization. The QuickVue^® At-Home OTC COVID-19 Test has not been FDA cleared or approved. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-partners-with-abbott-and-quidel-to-offer-rapid-otc-covid-19-tests-301351801.html

SOURCE Cardinal Health

BELLEVUE, Wash. and NEW YORK, Aug. 10, 2021 /PRNewswire/ — As part of a broad-reaching partnership to advance 5G-powered drone technology, T-Mobile (NASDAQ: TMUS), America’s 5G leader, and The Drone Racing League (DRL), the global, professional drone racing property, today launched their first 5G-enabled drone. This is one of the first racing drones in the world to have an embedded 5G module capable of live streaming video directly to the Internet. The drone will bring sports fans closer to the action than ever, streaming high-definition, immersive First Person View (FPV) race footage to broadcasters via T-Mobile’s 5G wireless network, America’s largest, fastest and most reliable.

This week the drone lifts off for its first public flight at the T-Mobile-sponsored MLB At Field of Dreams Presented by GEICO in Dyersville, Iowa, giving baseball fans unprecedented behind-the-scenes access to the iconic ballpark and movie site with exclusive first-person views captured over the T-Mobile 5G network in high-definition video. The 5G drone will take fans on a flight across the cornfields to the movie set to see the house and original ballfield, then on to the MLB field where the long-awaited Field of Dreams Game will be played.

“Drones are one of the most compelling use cases for 5G and we’re working towards a future where all drones will eventually be 5G-connected – that’s why we’ve teamed up with DRL, to fuel this innovation,” said Neville Ray, President of Technology at T-Mobile. “With the power of T-Mobile’s 5G network, we’re empowering innovators to completely reimagine virtually every industry and customer experience – from sports entertainment to disaster recovery, to parcel delivery and beyond.”

“The Drone Racing League is a perfect case study for showcasing the benefits of T-Mobile 5G wireless technology with our high-speed racing drones. Our fans love innovation and discovering how new technology is developed, and we know our 5G-enabled drone will get them excited about new ways they will be able to experience the immersive thrill of professional drone racing,” said DRL President Rachel Jacobson.

Throughout DRL’s 2021-22 Season, the 5G magenta drone will fly at DRL and T-Mobile events, capturing and sharing immersive content. Ahead of DRL events, the drone will soar around the course, filming exclusive previews of the complex, three-dimensional race tracks for fans tuning in on broadcast.

This new 5G-enabled drone is built to redefine sports entertainment, capturing exhilarating, crisp video footage. The drone has a dual FPV and HD streaming camera system, 5s lipo battery setup for extended flight time, and over 2,400g of thrust, enabling it to film incredible content through mile-long courses while flying over 60 MPH. In its next phase of development, the 5G module will connect the drone’s command and control functions to enable flight over T-Mobile 5G.

With 5G connectivity, this drone is designed to elevate the competition of professional drone racing in the future. DRL Pilots currently fly via analog radio transmissions for lower latency which sacrifices crisp quality footage in their goggles. As technical development of the drone advances, the speed, capacity, and low latency of T-Mobile’s 5G network will enable pilots to see instant high-quality and crisp FPV footage, enhancing their flying abilities. It will also enable fans to experience mesmerizing FPV clips on their mobile devices, giving them the sensation that they are flying inside the drone in real-time.

For a behind-the-scenes look at the development of the 5G drone, T-Mobile and DRL today released a mini-documentary video telling their journey of technical development and testing. The documentary chronicles the steps taken to bring this new technology to life, showcasing DRL engineers hand-building an initial prototype of the drone in the DRL lab in New York City and testing it for the first time on the T-Mobile 5G network.

Most Reliable: According to an audit report conducted by independent third party umlaut containing crowdsourced data for user experience collected from January to July 2021. Full details at: www.umlaut.com/en/benchmarking/USA. Fastest: According to Opensignal Awards –  USA: 5G User Experience Report July 2021 , based on independent analysis of average speeds from mobile measurements recorded during the period March 16 – June 13, 2021 © 2021 Opensignal Limited.

About T-Mobile

T-Mobile U.S. Inc. (NASDAQ: TMUS) is America’s supercharged Un-carrier, delivering an advanced 4G LTE and transformative nationwide 5G network that will offer reliable connectivity for all. T-Mobile’s customers benefit from its unmatched combination of value and quality, unwavering obsession with offering them the best possible service experience and undisputable drive for disruption that creates competition and innovation in wireless and beyond. Based in Bellevue, Wash., T-Mobile provides services through its subsidiaries and operates its flagship brands, T-Mobile, Metro by T-Mobile and Sprint. For more information please visit: http://www.t-mobile.com.

About Drone Racing League

The Drone Racing League (DRL) is the most innovative global sports, entertainment and tech property. The best drone pilots in the world fly in our league and millions of fans watch them race on NBC, Twitter, and Facebook. With groundbreaking technology and immersive, high-speed races through virtual and live events, DRL is creating a new era of sports, combining both esports and real-life competition.

Founded by Nicholas Horbaczewski in 2015, DRL is a privately held company headquartered in NYC. For more information, visit www.drl.io. To join the conversation, follow DRL on Facebook at facebook.com/thedroneracingleague, on Twitter @DroneRaceLeague, and on Instagram @thedroneracingleague.

Contacts

Media Contacts

T-Mobile US, Inc. Media Relations

[email protected]

Drone Racing League

Melanie Wallner, Director of Communications
[email protected]

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/t-mobile-and-the-drone-racing-league-launch-first-5g-enabled-drone-301351688.html

SOURCE Drone Racing League

BEVERLY, Mass., Aug. 10, 2021 /PRNewswire/ — Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company’s plans to participate in the following upcoming virtual investor conferences:

• The Needham Virtual 2^nd Annual SemiCap and EDA Conference, taking place Tuesday, August 24, 2021. Axcelis management will host one-on-one with interested investors. For more information on the conference, or to schedule a one-on-one meeting, please contact a Needham representative.
• The Jefferies 2021 Semiconductor, IT Hardware and Communications Infrastructure Summit, taking place Tuesday, August 31, 2021 and Wednesday, September 1, 2021 (Virtual). Axcelis management will host one-on-one and small group meetings on Tuesday, August 31^st with interested investors. For more information on the conference, or to schedule a one-on-one meeting, please contact a Jefferies representative.

About Axcelis:

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:

Maureen Hart (editorial/media) 978.787.4266
Doug Lawson (investor relations) 978.787.9552

View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-participation-in-upcoming-investor-conferences-301351441.html

SOURCE Axcelis Technologies, Inc.

NEW YORK, Aug. 10, 2021 /PRNewswire/ — Future FinTech Group Inc. (NASDAQ: FTFT) (“hereinafter referred to as Future FinTech”, “FTFT” or “the Company”), a leading blockchain-based e-commerce business and a fintech service provider, announced today that on August 6, 2021, the Company closed its acquisition of 90% of the issued and outstanding shares of Nice Talent Asset Management Limited (“NTAM”), a Hong Kong-based asset management company, from Joy Rich Enterprises Limited (“Joy Rich“).

As previously announced in the Company’s press releases on July 16, 2020 and April 12, 2021, the Company entered into a Share Exchange Agreement (the “Agreement”), amended on April 9, 2021 (the “Amendment”), with Joy Rich to acquire 90% of the issued and outstanding shares of NTAM.

NTAM is licensed under the Securities and Futures Commission of Hong Kong (“SFC”) to carry out regulated activities in ‘Type 4: Advising on Securities and ‘Type 9: Asset Management’. The Company has received approval from the SFC to become a substantial shareholder of NTAM. NTAM’s current business partners include major international banks and its clients are high net worth customers. Hong Kong is widely recognized as a leading asset management center in Asia with a large concentration of international fund managers.

Based upon a valuation report prepared for the Company by Greater China Appraisal Limited, a 100% equity interest of NTAM was valued at HK$189,338,353 in February 2021. Pursuant to the terms of the amended Agreement, the total purchase price for a 90% equity interest in NTAM (the “Purchase Price”) is HK$144,000,000 (approximately US$18,701,299), of which 60% of the Purchase Price, or HK$86,400,000 (approximately US$11,220,779) shall be paid in shares of common stock of the Company based on 95% of the closing price of the shares of Company’s common stock on the Nasdaq Stock Market prior to the date of the Amendment which is calculated to be $5.00 per share (the “FTFT Share Price”). The remaining 40% of the Purchase Price shall be paid in FTFT common stock (the “Earn-Out Shares”) according to the achievement of EBIT goals by NTAM for 2021 and 2022, as follows:

i. If NTAM achieves EBIT of HK$14,000,000 in 2021, the Company shall pay 20% of the Purchase Price, which is HK$28,800,000, in shares of common stock of the Company based on the FTFT Share Price;

ii. If NTAM achieves an EBIT of HK$20,000,000 in 2022, the Company shall pay the final 20% of the Purchase Price, which is HK$28,800,000, in shares of common stock of the Company based on the FTFT Share Price; and,

iii. If NTAM does not achieve its EBIT goals for a given year, a fee equal to ten times the EBIT shortfall amount shall be paid by Joy Rich to the Company before the Earn-Out Shares for that year are issued from the Company to Joy Rich.

More complete information of the Amendment is set forth in the Form 8-K and its exhibit filed with the Securities and Exchange Commission on April 12, 2021.

Mr. Shanchun Huang, Chief Executive Officer of Future FinTech, stated, “We are pleased to acquire 90% of Nice Talent Asset Management as it represents a major step forward in our ongoing expansion into the global financial services sector. We believe that there is a substantial opportunity to integrate fintech with boutique financial services and develop an innovative business model that meets that needs of the investment community for capital growth and total return as fintech further evolves the financial services sector in the years ahead. The Company plans upon creating synergies with our current capabilities to offer best-in-class asset management and investment consulting services for both corporate customers and high net-worth professional investors in Hong Kong.”

Mr. Chan Siu Kei, Chief Executive Officer and Director of NTAM stated, “The management team of NTAM includes former senior executives of HSBC and Hong Kong certified public accountants with deep experience in asset management and investment advisory services who also have extensive contacts in the industry in Hong Kong. We are excited to move forward with this highly strategic partnership with Future FinTech and their leading-edge approach in the financial services sector. Our business focus is to work alongside our clients to help them grow their wealth and achieve their investment goals. In every market environment, we specialize in uncovering potential sector winners and opportunities that align with clients’ interests while offering tailored and flexible investment strategies. We will leverage the additional resources, technology and platform provided by FTFT to further develop our business in Hong Kong and globally.”

In addition, due to a new and more strict regulatory policy recently announced by the Chinese government and China’s central bank regarding to the cryptocurrency sector, the Company has determined to terminate discussions related to its cryptocurrency and mining related potential acquisitions in China that it previously announced earlier this year. This pertains to the potential acquisition of a 51% equity interest in Mingtang Network Technology Co., Ltd., the potential acquisition of Nanjing Ribensi Electronic Technology Co., Ltd., and the potential acquisition of 20,000 Antminer bitcoin mining machines from Nanjing Shunru Electronic Technology Co., Ltd.

The Company also has terminated discussions related to the potential acquisition of 60% of the shares of Guang Dong Hi-Card Business Service Co., Ltd. as a result of the findings of its due diligence.

Despite the changes in circumstance of these potential acquisitions, the Company remains committed to its strategy of pursuing acquisitions for value creation and growth. We will be assessing new potential crypto mining farm and partnering opportunities in North America and the United Arab Emirates. We remain optimistic about our future opportunities to create a comprehensive financial services platform and fintech enterprise, and look forward to developing a strong competitive position in these sectors in the years ahead.

About Future FinTech Group Inc.

Future FinTech Group Inc. (“Future FinTech”, “FTFT” or the “Company”) is a leading blockchain e-commerce company and a service provider for financial technology incorporated in Florida. The Company’s operations include a blockchain-based online shopping mall platform, Chain Cloud Mall (“CCM”), an incubator for blockchain based application projects, and supply chain financing and services. The Company is also engaged in the development of blockchain based e-Commerce technology as well as financial technology. For more information, please visit http:/www.ftft.com/.

Safe Harbor Statement

Certain of the statements made in this press release are “forward-looking statements” within the meaning and protections of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause the actual results, performance, capital, ownership or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as “may,” “will,” “anticipate,” “assume,” “should,” “indicate,” “would,” “believe,” “contemplate,” “expect,” “estimate,” “continue,” “plan,” “point to,” “project,” “could,” “intend,” “target” and other similar words and expressions of the future.

All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary notice, including, without limitation, those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2020 and our other reports and filings with SEC. Such reports are available upon request from the Company, or from the Securities and Exchange Commission, including through the SEC’s Internet website at 
http://www.sec.gov
. We have no obligation and do not undertake to update, revise or correct any of the forward-looking statements after the date hereof, or after the respective dates on which any such statements otherwise are made.

View original content:https://www.prnewswire.com/news-releases/future-fintech-announces-closing-of-nice-talent-asset-management-acquisition-and-pending-acquisitions-update-301351523.html

SOURCE Future FinTech Group Inc.

MOORESTOWN, N.J., Aug. 10, 2021 /PRNewswire/ — Tabula Rasa HealthCare, Inc.â (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a newly signed agreement with PACE of Northeast Indiana (PACE of NEIN), the most recent Program of All-Inclusive Care for the Elderly (PACE®) organization established in Fort Wayne, Indiana serving Allen County. There are four additional PACE programs in the State.

PACE of NEIN will use TRHC’s comprehensive medication safety and pharmacy services, including medication risk mitigation, third party claims administration, risk adjustment, and pharmacy benefit services saving hours of administrative time and helping to provide better participant care.

Now, 100% of PACE organizations in Indiana work with TRHC for medication safety and pharmacy services. As a trusted partner to PACE organizations across the country, TRHC’s solutions and services are used by more than 90 percent of all PACE programs.

“When we began looking for a partner who could best help us deliver the most effective program support and efficient care for our Participants, we found that TRHC came with everything we needed,” says Katie Hougham, Vice President of PACE Operations for PACE of NEIN.

PACE® is the most comprehensive and coordinated program for value-based care of seniors with proven savings for Medicare and Medicaid. Through CareVention HealthCare, TRHC offers the only comprehensive, integrated suite of PACE® solutions, providing support to the PACE® market at all stages of development from feasibility assessment through application, start-up, implementation, and ongoing operations improvement.

“We welcome the opportunity to collaborate with PACE of Northeast Indiana providing them with the support to launch a successful program and advance their mission to help participants receive the best clinical and social care,” said TRHC Co-Founder and President, Orsula V. Knowlton, PharmD, MBA. “We believe strongly that programs like this can be the most effective path to meeting the healthcare needs of seniors at home in the community.”

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC’s proprietary technology solutions, including EireneRx® and MedWise®, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC’s CareVention HealthCare division provides clients, with medication fulfillment services, cloud-based software, pharmacy benefit management services, and clinical pharmacist services at the point-of-care. For more information, visit TRHC.com.

About PACE of Northeast Indiana
PACE (Programs of All-Inclusive Care for the Elderly) of Northeast Indiana is a Medicare and Medicaid program that combines clinical and social care in one setting. The Interdisciplinary Team – consisting of 11 disciplines – coordinates the person-centered care needed to meet the health care needs of Participants in the community instead of going into a nursing home or other care facility. PACE of Northeast Indiana is a collaborative effort between Aging & In-Home Services of Northeast Indiana (AIHS) and Parkview Health System. PACE of Northeast Indiana is the fifth program of its kind in Indiana and AIHS is the first Area Agency on Aging (AAA) to be a sponsoring organization of a PACE program. At Your PACE, Everything in ONE PLACE! For more information, visit https://www.pacenein.org/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pace-of-northeast-indiana-partners-with-tabula-rasa-healthcare-for-comprehensive-medication-safety-and-pharmacy-services-301351608.html

SOURCE Tabula Rasa HealthCare, Inc.